Topical 5% tranexamic acid for the treatment of melasma in Asians: A double-blind randomized controlled clinical trial
Background: Topical tranexamic acid has been claimed to lighten melasma without serious adverse effects. However, controlled studies assessing the efficacy and safety of topical tranexamic acid (TA) for the treatment of melasma is limited. Objective: To assess in a double blind, randomized, prospect...
Saved in:
Main Authors: | Pinyapat Kanechorn Na Ayuthaya, Nucha Niumphradit, Aranya Manosroi, Artit Nakakes |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84861083026&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/51883 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Topical 5% tranexamic acid for the treatment of melasma in Asians: A double-blind randomized controlled clinical trial
by: Ayuthaya P.K.N., et al.
Published: (2014) -
The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study
by: Rungsima Wanitphakdeedecha, et al.
Published: (2020) -
Stability and release of topical tranexamic acid liposome formulations
by: Manosroi A., et al.
Published: (2014) -
Does tranexamic acid in an irrigating fluid reduce intraoperative blood loss in orthognathic surgery? A double-blind, randomized clinical trial
by: Pariya Kaewpradub, et al.
Published: (2018) -
Topical isotretinoin for melasma in Thai patients: A vehicle-controlled clinical trial
by: Vichit Leenutaphong, et al.
Published: (2018)